Literature DB >> 6628498

Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

B Silke, G I Nelson, R C Ahuja, R C Okoli, S H Taylor.   

Abstract

To determine whether the depression of left ventricular pumping activity associated with beta-blockade alone could be offset by a substantial degree of partial agonist activity, the haemodynamic dose-response effects of intravenous propranolol and pindolol were compared in a randomised between-group saline controlled study in twenty patients with angiographically proven coronary artery disease. The intravenous doses of propranolol (2-16 mg) and pindolol (0.2-1.6 mg) used were selected on the basis of published reports of equivalence in terms of exercise blockade of chronotropic beta-adrenoceptors. Following four intravenous boluses of each drug, administered according to a cumulative log-dosage schedule, there was a log-linear increase in the plasma concentrations of each drug. The range of plasma concentrations achieved were those which have been shown to be associated with substantial attenuation of sympathetic stimulation of cardiac beta-adrenoceptors. At rest propranolol resulted in dose-related linear reductions in heart rate and cardiac output and linear increases in left heart filling pressure and systemic vascular resistance compared with saline-controlled measurements. The only statistically significant change at rest after pindolol was a small increase in the left heart filling pressure. The calculated systemic vascular resistance was increased after propranolol but unchanged after pindolol. During supine bicycle exercise the systolic blood pressure increased less after propranolol than after saline or pindolol. The increments in all other measured haemodynamic variables during exercise were equally influenced by the two drugs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628498     DOI: 10.1007/bf00543785

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  37 in total

1.  An analysis of the left ventricular response to isometric exercise.

Authors:  M A Quinones; W H Gaasch; E Waisser; H G Thiel; J K Alexander
Journal:  Am Heart J       Date:  1974-07       Impact factor: 4.749

2.  Effect of sustained isometric handgrip exercise on left ventricular performance.

Authors:  R H Helfant; M A De Villa; S G Meister
Journal:  Circulation       Date:  1971-12       Impact factor: 29.690

3.  Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.

Authors:  S H Taylor; B Silke; P S Lee; A Hilal
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

4.  Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.

Authors:  G Jennings; A Bobik; P Korner
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

5.  The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.

Authors: 
Journal:  JAMA       Date:  1981-11-06       Impact factor: 56.272

6.  Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.

Authors:  O Thulesius; J E Gjöres; E Berlin
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol.

Authors:  D R Ramsdale; E B Faragher; D H Bennett; C L Bray; C Ward; J M Cruickshank; S Yusuf; P Sleight
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

8.  Protective effect of propranolol in threatened myocardial infarction.

Authors:  R M Norris; E D Clarke; N L Sammel; W M Smith; B Williams
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

9.  Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

Authors:  P R Rossi; S Yusuf; D Ramsdale; L Furze; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

10.  Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol.

Authors:  U Menken; V Wiegand; P Bucher; W Meesmann
Journal:  Cardiovasc Res       Date:  1979-10       Impact factor: 10.787

View more
  3 in total

1.  Propranolol Reduces Cardiac Index But does not Adversely Affect Peripheral Perfusion in Severely Burned Children.

Authors:  Paul Wurzer; Ludwik K Branski; Robert P Clayton; Gabriel Hundeshagen; Abigail A Forbes; Charles D Voigt; Clark R Andersen; Lars-P Kamolz; Lee C Woodson; Oscar E Suman; Celeste C Finnerty; David N Herndon
Journal:  Shock       Date:  2016-11       Impact factor: 3.454

2.  Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?

Authors:  B Silke; S P Verma; R C Ahuja; M Hussain; M Hafizullah; G Reynolds; G I Nelson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.

Authors:  B Silke; M A Frais; S P Verma; G Reynolds; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.